In addition to inhibiting inflammatory response, daikenchuto can prevent peritoneal fibrosis by decreasing expression of HSP47, a collagen-specific molecular chaperone, and involved in the progression of peritoneal fibrosis [91, 92]. This evidence concerns the gene SERPINH1 and Peritoneal Fibrosis.